BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2006
View Archived Issues
Trials reveal efficacy of Hylan G-F 20 in osteoarthritis
Read More
Various agents being tested for efficacy in Sjogren's syndrome
Read More
CoFactor begins phase III study in metastatic colorectal cancer
Read More
SBIR grant supports ArmaGen's development of AGT-140 for stroke
Read More
Oncolys Biopharma licenses Ed4T for HIV-1 from Yale University
Read More
Dosing under way in phase IIa nociceptive pain study of cannabinor
Read More
Eisai licenses SERMS to Radius Health
Read More
Nabi and Kedrion sign European agreement for Civacir
Read More
North American phase III study of Miraxion achieves target enrollment
Read More
Phase IIa study of oleoyl-estrone now dosing patients
Read More
Characterization of SPI-256 mutational escape pathways
Read More
deCODE files to begin phase I studies of DG-051 for heart attack prevention
Read More
Polyphenon E Ointment review extended
Read More
NDA submission for CIP-Tramadol ER
Read More
New KB-2115 formulation completes phase I study
Read More
Vertex enters into agreement for VX-950, begins initiative in HCV
Read More
New River files IND for NRP-409
Read More
NDA submission for Zensana Oral Spray
Read More
Epix files appeal over Vasovist approvable letters
Read More
RotaTeq approved in Europe
Read More
THRX-165724 tested in AML cell lines
Read More
HET-0016 shows efficacy in a rat brain tumor model
Read More
CHMP recommends Keppra monotherapy in epilepsy
Read More
European approval for Kaletra tablet
Read More
XY-8: Novel water-soluble camptothecin derivative active in preclinical tumor models
Read More
Novel norepinephrine and serotonin reuptake inhibitors imparted by Pfizer
Read More
Recent Abbott patent discloses novel vanilloid VR1 receptor antagonists
Read More
New antiinfective agents disclosed in recent patents
Read More
MS-560 demonstrates selectivity against matrix metalloproteinases involved in atherosclerosis
Read More
Promising preliminary results of phase I/II trial of ofatumumab in rheumatoid arthritis
Read More